Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2012 Oct:23 Suppl 7:vii72-7. doi: 10.1093/annonc/mds228.

Authors

M Baccarani¹, S Pileri, J-L Steegmann, M Muller, S Soverini, M Dreyling; ESMO Guidelines Working Group

Affiliation

¹ Department of Hematology-Oncology L and A. Seràgnoli, University of Bologna, Italy.

PMID: 22997458
DOI: 10.1093/annonc/mds228

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / therapeutic use
Disease Management
Drug Resistance, Neoplasm
Genes, abl
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Molecular Targeted Therapy
Prognosis
Protein Kinase Inhibitors / therapeutic use
Risk
Treatment Outcome

Substances

Antineoplastic Agents
Protein Kinase Inhibitors